Quantcast

Posts related to ‘BMY’

24/7 Wall St. Closing Bell (GD, VALE, GMCR, GLW, CHK, ARG, ACAT, T, BMY, CAT, CY, LMT, MKC, MWW, POT, RTN, VIST, RNWK, MNTA, NFLX, EFSC)

All three major US indexes opened higher this morning, but enthusiasm tapered off quickly and steadily, if not sharply. A drop in the number of new home sales and a ...
Read Full Story »

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp ...
Read Full Story »

What’s Important in the Financial World (1/9/2012) Chevy Volt Revivial, M&A Monday

Deal makers were busy over the weekend. Strategic considerations were more the driver of activity than an improved economy, however. Lions Gate Entertainment (NYSE: LGF) will buy Summit Entertainment for ...
Read Full Story »

Media Digest (1/9/2012) Reuters, WSJ, NYT, FT, Bloomberg

http://platform.twitter.com/widgets/hub.1324331373.htmlThe U.S. may start legal proceedings against Swiss financial firm Wegelin & Co. based on beliefs that it helped shield Americans from taxes. (Reuters) The EPA may send fresh water ...
Read Full Story »

Media Digest (11/30/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

The EU continues to work on its bailout fund and may ask the IMF for help. (Reuters) American Airlines parent AMR (NYSE: AMR) files for Chapter 11. (Reuters) S&P cuts its ...
Read Full Story »

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like ...
Read Full Story »

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

The DJIA jumped above 12,000 in the opening minutes of trading this morning and had topped 12,200 by mid-afternoon. European Union leaders have agreed on a deal that would ...
Read Full Story »

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will ...
Read Full Story »

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public.  So what about when a company decides to unlock shareholder value by ...
Read Full Story »

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription ...
Read Full Story »

America’s Recession-Proof Companies

With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AMSF, BMY, BRCM, CBST, HOV, INTC, JNJ, KBH, LEN, LULU, MAKO, NFLX, ASGN, OKS, TSLA, TWX, YHOO, YOKU)

These are some of this Thursday's top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Amerisafe, Inc. (NASDAQ: AMSF) named Bear of the Day ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AMAT, CAR, BMY, BRCM, CTRN, CL, ENB, HUN, LRCX, MU, PIR, RENN, TEF)

These are some of this Monday's top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Applied Materials Inc. (NASDAQ: AMAT) Cut to Sell at ...
Read Full Story »

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in a study that shows it lowers risk from a type ...
Read Full Story »

Media Digest (8/29/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

LG Display (NYSE: LPL) cuts capital expenditures as demand for LCD screens is hurt by tablet PC sales. (Reuters) Samsung to delay its tablet launch in the U.S. because of ...
Read Full Story »